Back in 2019, CBD was the “new” cannabinoid on the market. People had questions, brands were popping up everywhere, and suddenly CBD was in everything from sparkling waters to skincare products to dog treats. Fast forward seven years, and CBD has become mainstream. Consumers are more educated, products are more accessible (for now), and the conversation around cannabinoids has expanded far beyond THC and CBD.

Now, another cannabinoid is starting to get more attention: CBG.

Short for cannabigerol, CBG is often referred to as the “mother cannabinoid,” and while it’s been around for thousands of years, researchers, brands, and consumers are only recently starting to explore its potential. If you’ve started seeing CBG gummies, tinctures, or beverages on shelves and wondering what makes it different, you’re not alone.

Here’s what you should know.

CBG stands for cannabigerol, a naturally occurring cannabinoid found in cannabis and hemp plants. While cannabinoids like THC and CBD tend to dominate the conversation, CBG actually plays an important role in how those compounds are formed in the first place.

In its acidic form, CBG starts as CBG-A (cannabigerolic acid). As the cannabis plant matures, enzymes break CBG-A down into other cannabinoids like THC-A, CBD-A, and CBC-A, which later become THC, CBD, and CBC through decarboxylation.

That’s why CBG is often called the “mother of all cannabinoids.” Without CBG-A, many of the cannabinoids we know today wouldn’t exist.

The interesting thing is that because so much CBG-A converts into other cannabinoids during the plant’s growth cycle, mature cannabis plants typically contain only trace amounts of CBG. That rarity is part of why CBG products have taken longer to hit the market in a meaningful way. It’s harder to extract from the plant than CBD or THC.

One of the biggest misconceptions in cannabis is that all cannabinoids basically do the same thing. They don’t.

While CBD and CBG are both non-intoxicating cannabinoids, meaning they won’t produce the “high” associated with THC, they interact with the body differently and are often used for different wellness goals.

CBD is generally known for relaxation, stress management, and overall wellness support. Many consumers turn to CBD for calming effects, sleep support, or recovery.

CBG, on the other hand, is often associated with focus, balance, and cognitive support. Many users describe it as calming without making them feel sleepy or sluggish. Some even compare the experience to feeling more clear-headed or mentally dialed in.

Another key difference is how they interact with the body’s endocannabinoid system (ECS). Research suggests CBD works more indirectly with cannabinoid receptors, while CBG appears to interact more directly, though still relatively weakly, with CB1 and CB2 receptors.

That distinction may help explain why the experience of CBG can feel noticeably different from CBD for some consumers.

Like other cannabinoids, CBG interacts with the body’s endocannabinoid system, or ECS.

The ECS is a complex cell-signaling system that helps regulate important functions like mood, stress response, sleep, appetite, inflammation, and overall balance within the body. Think of it as one of the body’s built-in systems for maintaining homeostasis.

CBG is believed to interact primarily with CB1 receptors, which are concentrated in the brain and nervous system, and CB2 receptors, which are found more heavily throughout the immune system and peripheral organs.

Researchers are still studying exactly how CBG works and what makes it unique. The reality is we’re still in the early stages of cannabinoid science as a whole. While there’s promising research and growing consumer interest, much of the evidence around CBG is still emerging.

That’s important to remember anytime you see bold claims attached to any cannabinoid product.

This is where the excitement around CBG really comes in.

Early research and anecdotal reports suggest CBG may offer a range of potential wellness benefits, though more human studies are still needed to fully understand its effects.

Some of the most talked-about potential benefits include:

One reason consumers are gravitating toward CBG is because many describe it as functional. Instead of using cannabinoids only at night or for relaxation, some people incorporate CBG into their daytime wellness routines because they feel it helps them stay balanced and focused without the jittery feeling that can come from caffeine-heavy products.

That said, everyone’s body responds differently to cannabinoids. What works well for one person may not work the same way for someone else.

CBG products are becoming much easier to find, especially as hemp brands continue expanding beyond traditional CBD offerings.

You’ll most commonly see CBG in:

Many products actually combine CBG with CBD to create a broader cannabinoid profile. Some brands also formulate CBG with functional ingredients like adaptogens, mushrooms, or vitamins depending on the intended effect.

If you’re new to CBG, the best approach is the same advice that applies to most cannabinoids: start low and go slow.

Pay attention to dosage, how your body responds, and when you’re taking it. A lower dose during the daytime may feel very different than a higher dose in the evening.

And as always, quality matters. Not all cannabinoid products are created equally, so look for brands that provide third-party lab testing and transparent ingredient information.

The cannabis conversation is evolving. Consumers are becoming more educated, products are becoming more targeted, and cannabinoids beyond THC and CBD are finally getting the attention they deserve.

CBG isn’t some magic cure-all, and the research still has a long way to go. But it is an interesting example of how nuanced cannabis really is. Different cannabinoids can create completely different experiences, and understanding those differences helps consumers make more informed choices.

As the industry continues to mature, expect to hear a lot more about cannabinoids like CBG, CBN, and CBC. We’re only scratching the surface of what these compounds may be capable of.

Join the Cannaverse for Minnesota cannabis updates, events, and community spotlights delivered weekly.

Sources:

Lu HC, Mackie K. Review of the Endocannabinoid System. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607-615.

Li S, Li W, Malhi NK, Huang J, et al. Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential. Molecules. 2024;29(22):5471.

https://cbd-alchemy.com/en/blog/cannabis-terpenes-guide/